Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practice.
Gevaert
Olivier
O
Pochet
Nathalie
N
De Smet
Frank
F
Van Gorp
Toon
T
De Moor
Bart
B
Timmerman
Dirk
D
Amant
Frédéric
F
Vergote
Ignace
I
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D011379:Prognosis
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D002945:Cisplatin